J Korean Radiol Soc.  2007 Aug;57(2):121-127. 10.3348/jkrs.2007.57.2.121.

Cinical Application of Iopamidol (Pamiray(R) 300) for Cerebral Angiography

Affiliations
  • 1Department of Diagnostic Radiology, Yonsei University College of Medicine, Korea. dikim@yumc.yonsei.ac.kr

Abstract

PURPOSE
The aim of this study was to assess the clinical safety and efficacy of Pamiray(R) 300 (Iopamidol; Dongkook Pharm., Seoul, Korea) as a nonionic contrast medium for cerebral angiography.
MATERIALS AND METHODS
One hundred patients undergoing cerebral angiography were randomly assigned to receive Pamiray(R) 300 after written consent had been obtained. Patients with adverse reactions were divided into two groups. One group consisted of patients with minor adverse events such as heat sensation and pain, and the other group consisted of patients with major adverse events such as dyspnea, laryngeal edema and shock. The qualities of the radiographic images were stratified into five grades by three independent radiologists.
RESULTS
No abnormality induced by Pamiray(R) 300 was seen by a physical and neurological examination, blood pressure measurement, electrocardiogram, respiration rate measurement and partial fraction of arterial oxygen recording. No major and severe adverse events occurred throughout the study. Patient sex, age, disease category, underlying disease and administered contrast dosage showed no statistical significance with regards to the occurrence of adverse events. The opacification of blood vessels in all patients was 'good' or 'excellent'.
CONCLUSION
Based on the results of this study, Pamiray(R) 300 is a safe, efficacious and well-tolerated contrast medium for use in cerebral angiography. Thus, Pamiray(R) 300 can be used as a competitive medium in cerebral angiography.

Keyword

Angiography; Cerebral angiography

MeSH Terms

Angiography
Blood Pressure
Blood Vessels
Cerebral Angiography*
Dyspnea
Electrocardiography
Hot Temperature
Humans
Iopamidol*
Laryngeal Edema
Neurologic Examination
Oxygen
Respiratory Rate
Sensation
Seoul
Shock
Iopamidol
Oxygen
Full Text Links
  • JKRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr